Scarica l'app Stockscreener
1.99
2.93%
-0.06
Dopo l'orario di chiusura:
1.99
Precedente Chiudi:
$2.05
Aprire:
$2.1
Volume 24 ore:
323.55K
Relative Volume:
1.03
Capitalizzazione di mercato:
$51.90M
Reddito:
$1.79M
Utile/perdita netta:
$-70.90M
Rapporto P/E:
-0.1281
EPS:
-15.54
Flusso di cassa netto:
$-34.95M
1 W Prestazione:
-1.00%
1M Prestazione:
-0.50%
6M Prestazione:
-57.84%
1 anno Prestazione:
-12.33%
Intervallo 1D:
$1.96
$2.10
Intervallo di 1 settimana:
$1.86
$2.12
Portata 52W:
$1.5201
$16.94
Senti Biosciences Inc Stock (SNTI) Company Profile
Nome
Senti Biosciences Inc
Settore
Industria
Telefono
(650) 382-3281
Indirizzo
2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO
Confronta SNTI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNTI
Senti Biosciences Inc
|
1.99 | 51.90M | 1.79M | -70.90M | -34.95M | -15.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Senti Biosciences Inc Stock (SNTI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-06 | Iniziato | Laidlaw | Buy |
| 2022-10-07 | Iniziato | Morgan Stanley | Equal-Weight |
Senti Biosciences Inc Borsa (SNTI) Ultime notizie
Can Senti Biosciences Inc. stock recover from recent declineUnstoppable trading performance - jammulinksnews.com
What analysts say about Senti Biosciences Inc. stockFree Real-Time Stock Data - Autocar Professional
Is Senti Biosciences Inc. a good long term investmentAccelerated capital growth - jammulinksnews.com
What drives Senti Biosciences Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
Senti Biosciences Inc. Stock Analysis and ForecastFree Consultation - jammulinksnews.com
Senti Biosciences Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times
What makes Senti Biosciences Inc. stock price move sharplyProtected Capital Trading Plan - Newser
Exclusive: Senti Bio CEO Reveals Personal Journey and Strategic Vision for Gene Circuit Platform - Stock Titan
Solid Biosciences Inc. shares rise 3.29% premarket after Senti Bio's presentation at BioScience Forum. - AInvest
Senti Bio’s Chief Medical Officer, Kanya Rajangam, M.D., Ph.D. to Give Feature Presentation at the BioScience Forum - The Manila Times
Senti Bio to present logic-gated CAR-NK cell therapy at BioScience Forum - Investing.com
Why Senti Biosciences Inc. stock attracts strong analyst attentionFree Step-by-Step Investment Guide - beatles.ru
Senti Bio Appoints Bryan Baum to Board of Directors, Aims for Growth with New Expertise. - AInvest
Senti Biosciences Appoints Bryan Baum to Board, Enhancing Strategic Direction and Optimizing Value for Stakeholders - AInvest
Bryan Baum Joins Senti Biosciences Board of Directors - AInvest
Sweetgreen, Inc. shares rise 3.77% intraday after Senti Biosciences, Inc. appoints Bryan Baum to its Board of Directors. - AInvest
Senti Biosciences Appoints Bryan Baum to Board - TipRanks
Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors By Investing.com - Investing.com South Africa
Senti Bio appoints K5 Global co-founder Bryan Baum to board of directors - Investing.com
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors - The Manila Times
Is Senti Biosciences Inc. stock overhyped or has real potentialLow Risk ROI Maximization - Newser
How Senti Biosciences Inc. stock performs during market volatilityStrong Buy Recommendations - Newser
SNTI’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Senti Biosciences Stock Faces Decline Amid Market Challenges - timothysykes.com
Senti Biosciences Soars 32.39% on Promising Clinical Trial Results - AInvest
Senti Biosciences (NASDAQ:SNTI) Upgraded by Wall Street Zen to “Sell” Rating - Defense World
Senti Biosciences (NASDAQ:SNTI) Trading Up 2.5% – Here’s What Happened - Defense World
Senti Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks
Senti Bio Participates in Nasdaq Amplify Spotlight Series - TradingView
Senti Biosciences, Inc.(NasdaqCM: SNTI) added to Russell 3000E Value Index - MarketScreener
SNTI SEC FilingsSenti Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan
Is Senti Biosciences, Inc. overvalued or undervalued? - MarketsMojo
Senti Biosciences Inc Azioni (SNTI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):